![]() | Daniela TonioloShow email addressDivision of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy. | Division of Genetics and Cell Biology, San Raffaele Research Institute and Vita ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
Daniela Toniolo:Expert Impact
Concepts for whichDaniela Toniolohas direct influence:Premature ovarian failure,Cpg islands,Serum hepcidin,Muscular dystrophy,Critical region,Barth syndrome,Platelet count,Association analysis.
Daniela Toniolo:KOL impact
Concepts related to the work of other authors for whichfor which Daniela Toniolo has influence:Barth syndrome,Gene expression,Blood pressure,Nuclear envelope,Muscular dystrophy,Dna methylation,Mental retardation.
KOL Resume for Daniela Toniolo
Year | |
---|---|
2021 | Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy. |
2019 | Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milano, Italy |
2018 | Divisione di Genetica e Biologia Cellulare, Istituto Scientifico San Raffaele, Milano, Italy;, View further author information |
2017 | Genetics of Common Disorders Unit, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy |
2016 | Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milano, Italy. San Raffaele Research Institute, Milano, 20132 Italy; Institute of Molecular Genetics-CNR, Via Abbiategrasso 207, Pavia 27100, Italy |
2015 | Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Via Olgettina 58, Milano, 20132, Italy. Department of Psychiatry, Trinity Centre for Health Sciences, St James Hospital, James's Street, Dublin 8, Ireland Institute of Molecular Genetics, National Research Council (CNR), Pavia, Italy |
2014 | Institute of Molecular Genetics-CNR, Pavia, Italy |
2013 | CNR Institute of Molecular Genetics, Pavia, Italy; Division of Genetics and Cell Biology, San Raffaele Research Institute and Vita Salute University, Milano, Italy |
2012 | Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy and Institute of Molecular Genetics-CNR, Pavia, Italy Milano |
2011 | Institute of Molecular Genetics, National Research Council of Italy, Pavia Unit of Genetics of Common Disorder, Division of Genetics and Cell Biology, Istituto Scientifico San Raffaele, Milan, Italy; and |
2010 | Institute of Molecular Genetics-CNR, 20182 Pavia, Italy |
2009 | Department of Biotechnological Research (DIBIT), San Raffaele Scientific Institute, Milano, Italy |
2008 | Dipartimento di Ricerca Biotecnologica (DIBIT), IRCCS San Raffaele, Milano, Italy DIBIT-San Raffaele Scientific Institute |
2007 | From the Laboratory of Clinical Molecular Biology (S.B., I. Menditto, P.C., M.F.), Diagnostica e Ricerca San Raffaele, Milan; Biocrystallography Unit (M.D.), Department of Medicine (R.C.), and Neuropathology Unit and Department of Neurology and INSPE (R.F., G.C., A.Q., S.C.P.), San Raffaele Scientific Institute, Milan; Department of Neurosciences, Psychiatry and Anesthesiology (C.R., A.T.), AOU “G. Martino,” Messina; Neuromuscular Unit (L. Merlini), Department of Medical Genetics, University of Ferrara; Unit of Molecular Medicine (A.D., E.B.), Ospedale Bambino Gesù Research Hospital, Rome; P. Peirolo Centre for Neuromuscular Diseases (L.P.), Department of Neuroscience, University of Torino; Department of Child Neurology and Psychiatry (A.B.), IRCCS “C. Mondino” Foundation, Pavia; Departments of Neurosciences (E.P.) and Neurological and Psychiatric Sciences (C.P.T.), University of Padova; Division of Neuromuscular Diseases (L. Morandi, I. Moroni), Istituto Nazionale Neurologico C. Besta, Bicocca Laboratories, Milan; Laboratory of Molecular Genetics (G.G.), UILDM-Sez. Laziale, Rome, Italy; Institute of Neuropathology (M.O.), IDIBELL-Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain; Inserm, U582 (G.B.), Institut de Myologie; Université Pierre et Marie Curie-Paris 6, UMR S582 (G.B.), IFR14; and AP-HP, Groupe Hospitalier Pitié-Salpêtrière (G.B.), UF Cardiogenetic and Myogenetics, Paris, France; Medical Genetics (F.M.), University of Siena, Policlinico “S. Maria alle Scotte,” Siena; Ambulatorio Genetica Medica (I. Mammì), USSL 13, Ospedale di Dolo, Venezia; Unit for Genomics for Human Disease Diagnosis (P.C., M.F.), San Raffaele Scientific Institute, Milan; Dibit-San Raffaele Scientific Institute (D.T.), Milan; and Università Vita-Salute San Raffaele (G.C., S.C.P.), Milan, Italy. DIBIT, San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy |
2006 | DIBIT, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milano, Italy |
2005 | Institute of Molecular Genetics-CNR, Via Abbiategrasso 207, Pavia, Italy |
2004 | Dibit-San Raffaele Scientific Institute, Milano, Italy |
2003 | Institute of Genetics, Biochemistry and Evolution-CNR, Pavia, Italy |
2002 | DIBIT–HSR, Milan, Italy |
2001 | Institute of Genetics, Biochemistry and Evolution, CNR, Via Abbiategrasso 207, 27100 Pavia, Italy |
2000 | Institute of Genetics, Biochemistry and Evolution, Consiglio Nazionale delle Recherche, Via Abbiategrasso 207, 27100 Pavia, Italy |
1999 | Consiglio Nazionale delle Richerche Institute of Genetics, Biochemistry and Evolution, Pavia, Italy |
1998 | Instituto di Genetica Biochimica ed Evoluzionistica, Via Abbiategrasso 207, 27100 Pavia, Italy Dipartimento di Biotecnologie, Milan |
1997 | Institute of Genetics Biochemistry and Evolution, CNR, 27100, Pavia, Italy |
1996 | Istituto di Genetica Biochimica ed Evoluzionistica, CNR, Pavia, Italy DIBIT‐HSR, Milan Institute of Genetics, Biochemistry and Evolution, Pavia |
1995 | Consiglio Nazionale delle Ricerche, Istituto di Genetica Biochimica ed Evoluzionistica, Via Abbiategrasso 207, 27100, Pavia, Italy |
Concept | World rank |
---|---|
lamin defects lmna | #1 |
fine mapping chromosomespecific | #1 |
nigerian chromosome | #1 |
val borbera | #1 |
cytoplasm muscle fibres | #1 |
general strategy ambiguities | #1 |
xedmd gene | #1 |
85–95 years women | #1 |
genetic pof | #1 |
gdx dxs253e | #1 |
mild muscle disorder | #1 |
250 kb | #1 |
g45 gene bths | #1 |
rflp british | #1 |
g6pd deduced | #1 |
demethylation specific regions | #1 |
g6pd human | #1 |
4generation sardinian | #1 |
enzymes dinucleoside | #1 |
probes cpg | #1 |
extent deletions comparison | #1 |
sardinia g6pd variants | #1 |
human inha gene | #1 |
xlinked pof presence | #1 |
dominant lmna mutations | #1 |
emerin lymphoblastoid | #1 |
northern italy genealogy | #1 |
structural gene g6pd | #1 |
gdx aging blotting | #1 |
16 obligate carriers | #1 |
32ppgd3 | #1 |
g6pd modena seattle | #1 |
dxs253e lambda g28 | #1 |
islands xq24 | #1 |
young individuals pacemaker | #1 |
69 mrx loci | #1 |
region g6pd | #1 |
poi pathogenesis poi | #1 |
inha promoter variants | #1 |
incorrect localization lack | #1 |
human g6pd level | #1 |
mental impairment development | #1 |
257 restriction fragments | #1 |
mutation lmna gene | #1 |
localisation pof1b | #1 |
lambda g28 | #1 |
artificial thymopoietins | #1 |
ubiquitous protein emerin | #1 |
entire genealogies | #1 |
Sign-in to see all concepts, it's free! | |
Prominent publications by Daniela Toniolo
Clinical and molecular genetic spectrum of autosomal dominant Emery‐Dreifuss muscular dystrophy due to mutations of the lamin A/C gene
[ PUBLICATION ]
Emery-Dreifuss muscular dystrophy (EDMD) is characterized by early contractures of the elbows and Achilles tendons, slowly progressive muscle wasting and weakness, and life-threatening cardiomyopathy with conduction blocks. We recently identified LMNA encoding two nuclear envelope proteins, lamins A and C, to be implicated in the autosomal dominant form of EDMD. Here, we report on the variability of the phenotype and spectrum of LMNA mutations in 53 autosomal dominant EDMD patients (36 ...
Known for Lmna Mutations | Autosomal Dominant | Muscular Dystrophy | Cardiac Involvement | Muscle Weakness |
Monoclonal B-cell lymphocytosis (MBL) is classified as chronic lymphocytic leukemia (CLL)-like, atypical CLL, and CD5(-) MBL. The number of B cells per microliter divides CLL-like MBL into MBL associated with lymphocytosis (usually detected in a clinical setting) and low-count MBL detected in the general population (usually identified during population screening). After a median follow-up of 34 months we reevaluated 76 low-count MBLs with 5-color flow cytometry: 90% of CLL-like MBL but ...
Known for Cll Mbl | Fluorescence Leukemia | Situ Hybridization | Human Pair | Cell Count |
Objective: To assess the frequency of variants, including biallelic pathogenic variants, in minichromosome maintenance 8 (MCM8) and minichromosome maintenance 9 (MCM9), other genes related to MCM8-MCM9, and DNA damage repair (DDR) pathway in participants with primary ovarian insufficiency (POI).
Design: MCM8, MCM9, and genes encoding DDR proteins that have been implicated in reproductive aging were sequenced among POI participants.
Setting: Academic research institution.
Participants: ...
Known for Primary Ovarian Insufficiency | Minichromosome Maintenance | Mcm9 Genes | Reproductive Aging | Variants Mcm8 |
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
[ PUBLICATION ]
Emery-Dreifuss muscular dystrophy (EDMD) is characterized by early contractures of elbows and Achilles tendons, slowly progressive muscle wasting and weakness, and a cardiomyopathy with conduction blocks which is life-threatening1. Two modes of inheritance exist, X-linked (OMIM 310300) and autosomal dominant (EDMD-AD; OMIM 181350). EDMD-AD is clinically identical to the X-linked forms of the disease2,3,4. Mutations in EMD, the gene encoding emerin, are responsible for the X-linked ...
Known for Autosomal Dominant | Gene Encoding | Dreifuss Muscular | Mutations Emd | Sequence Homology |
In the revised National Cancer Institute Working Group (NCI-WG)/International Workshop on Chronic Lymphocytic Leukemia (IWCLL) guidelines for CLL, CLL-like monoclonal B lymphocytosis (MBL) is defined as the presence of less than 5 x 10(9)/L B lymphocytes in the peripheral blood. However, the concentration of MBL in the blood is extremely variable. MBL in subjects with lymphocytosis require treatment at a rate of 1.1% per year and present immunoglobulin (IG) gene features and similar to ...
Known for Cll Mbl | Lymphocytic Leukemia | Clinical Monitoring | Gene Repertoire | Count Lymphocytosis |
Rab proteins are small GTPases involved in intracellular trafficking. Among the 60 different Rab proteins described in mammals, Rab3a is the most abundant in brain, where it is involved in synaptic vesicle fusion and neurotransmitter release. Rab3a constitutive knockout mice (Rab3a(-/-)) are characterized by deficient short- and long-term synaptic plasticity in the mossy fiber pathway and altered circadian motor activity, while no effects on spatial learning have been reported so far for ...
Known for Rab3a Mice | Reversal Learning | Animal Conditioning | Synaptic Vesicle | Spatial Memory |
BACKGROUND: Hepcidin is the main regulator of iron homeostasis: inappropriate production of hepcidin results in iron overload or iron deficiency and anaemia.
AIMS: To study variation of serum hepcidin concentration in a normal population.
RESULTS: Hepcidin showed age and sex dependent variations that correlated with ferritin but not with serum iron and transferrin saturation. The size of the study population was underpowered to find genome wide significant associations with hepcidin ...
Known for Serum Hepcidin | Iron Parameters | Transferrin Saturation | Tmprss6 Genetic | Association Hfe |
Human Mental Retardation (MR) is a common and highly heterogeneous pediatric disorder affecting around 3% of the general population; at least 215 X-linked MR (XLMR) conditions have been described, and mutations have been identified in 83 different genes, encoding proteins with a variety of function, such as chromatin remodeling, synaptic function, and intracellular trafficking. The small GTPases of the RAB family, which play an essential role in intracellular vesicular trafficking, have ...
Known for Linked Mental | Small Gtpase | Gene Rab39b | Intracellular Trafficking | Synaptic Function |
A Mutation in the Rett Syndrome Gene, MECP2, Causes X-Linked Mental Retardation and Progressive Spasticity in Males
[ PUBLICATION ]
Heterozygous mutations in the X-linked MECP2 gene cause Rett syndrome, a severe neurodevelopmental disorder of young females. Only one male presenting an MECP2 mutation has been reported; he survived only to age 1 year, suggesting that mutations in MECP2 are male lethal. Here we report a three-generation family in which two affected males showed severe mental retardation and progressive spasticity, previously mapped in Xq27.2-qter. Two obligate carrier females showed either normal or ...
Known for Rett Syndrome | Linked Mental | Males Mecp2 | Progressive Spasticity | Preschool Chromosomal Proteins |
Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy
[ PUBLICATION ]
BACKGROUND AND PURPOSE: Emery-Dreifuss muscular dystrophy (EDMD) is a rare inherited disorder associated with cardiac involvement. We investigated the spectrum and relevance of the cardiac manifestations of EDMD, focusing on bradyarrhythmias and tachyarrhythmias (including atrial fibrillation/flutter), embolic stroke, and heart failure.
METHODS AND RESULTS: Eighteen patients (age 42.8+/-19.6 years) with genetically confirmed X-linked (n=10, including 3 carriers) or autosomal dominant ...
Known for Heart Failure | Atrial Fibrillation | Muscular Dystrophy | Pacemaker Implant | Cardiac Involvement |
Different Mutations in the LMNA Gene Cause Autosomal Dominant and Autosomal Recessive Emery-Dreifuss Muscular Dystrophy
[ PUBLICATION ]
Emery-Dreifuss muscular dystrophy (EMD) is a condition characterized by the clinical triad of early-onset contractures, progressive weakness in humeroperoneal muscles, and cardiomyopathy with conduction block. The disease was described for the first time as an X-linked muscular dystrophy, but autosomal dominant and autosomal recessive forms were reported. The genes for X-linked EMD and autosomal dominant EMD (AD-EMD) were identified. We report here that heterozygote mutations in LMNA, ...
Known for Lmna Gene | Autosomal Dominant | Dreifuss Muscular | Recessive Emery | Progressive Weakness |
Barth syndrome (BTHS) is a rare X-linked recessive disorder characterized by cardiac and skeletal myopathy, neutropenia, and short stature. A gene for BTHS, G4.5, was recently cloned and encodes several novel proteins, named "tafazzins." Unique mutations have been found. No correlation between the location or type of mutation and the phenotype of BTHS has been found. Female carriers of BTHS seem to be healthy. This could be due to a selection against cells that have the mutant allele on ...
Known for Chromosome Inactivation | Barth Syndrome | Skewed Pattern | Female Carriers | Phenotype Bths |
Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies
[ PUBLICATION ]
Vascular endothelial growth factor (VEGF) is an angiogenic and neurotrophic factor, secreted by endothelial cells, known to impact various physiological and disease processes from cancer to cardiovascular disease and to be pharmacologically modifiable. We sought to identify novel loci associated with circulating VEGF levels through a genome-wide association meta-analysis combining data from European-ancestry individuals and using a dense variant map from 1000 genomes imputation panel. ...
Known for Vegf Levels | Genome Wide | Endothelial Cells | Cardiovascular Disease | European Ancestry |